Latest in News & Research

Suicidal Ideation Risk Elevated for Patients With Atopic Eczema

Key predictors of suicidal ideation included younger age and obesity, as well as pruritus, skin pain, symptom intensity

By Elana Gotkine (HealthDay News) | | September 17, 2025

DermaRite Widens Recall to 32 Products Over Bacteria Risk

Recalled items include body washes, lotions, soaps, shampoos, sanitizers and wound cleansers sold nationwide and in Puerto Rico

By India Edwards (HealthDay News) | | September 17, 2025

Diagnostic Excisional Biopsies With Clear Margins Sufficient for Melanoma in Situ

In study, only one local recurrence seen in patient with involved margins at the excisional biopsy who did not undergo wide excision

By Dermsquared Editorial Team | | September 09, 2025

Holistic Approach Recommended for Rosacea in Pregnancy

Patients face emotional distress and their babies may have physical harm from treatment

By Dermsquared Editorial Team | | September 09, 2025

DermaRite Expands Recall of Creams and Sanitizers Over Infection Risk

Products may be contaminated with bacteria that can cause serious infections

By India Edwards (HealthDay News) | | September 09, 2025

High Clearance of Superficial BCC Seen With Photodynamic Therapy With 10% 5-Aminolevulinic Acid Gel

Histologic and clinical clearance higher with photodynamic therapy with 10 percent ALA gel versus vehicle

By Dermsquared Editorial Team | | September 03, 2025

Global Prevalence of Hidradenitis Suppurativa Estimated at 0.99 Percent

Female sex was the only factor associated with prevalence estimates

By Dermsquared Editorial Team | | September 03, 2025

N-NAIL Score More Accurate Than NAPSI for Diagnosing Nail Psoriasis

Both NAPSI and N-NAIL provide accurate cutoffs, but better accuracy seen with N-NAIL, with cutoff value of 2

By Elana Gotkine (HealthDay News) | | September 03, 2025

Metabolic Syndrome, Circadian Syndrome Linked to Melanoma Risk

Stronger associations seen in men; risk for melanoma increases sharply when more than two components of MetS present in men

By Dermsquared Editorial Team | | August 26, 2025

Risk for Serious Infection Up With Adalimumab Use in Hidradenitis Suppurativa Versus Psoriasis

Patients with hidradenitis suppurativa have increased likelihood of sepsis, genitourinary infection versus those with psoriasis

By Dermsquared Editorial Team | | August 26, 2025

High Response to PD-1 Therapy Seen in Unresectable Desmoplastic Melanoma

Complete response rate was 37 percent, and post-hoc end point of objective response rate was 89 percent

By Elana Gotkine (HealthDay News) | | August 26, 2025

Potential Benefits Seen for GLP-1 RAs in Hidradenitis Suppurativa Management

At six months, 50 to 60 percent of patients achieved a 1-point or higher reduction in HS Physician's Global Assessment

By Dermsquared Editorial Team | | August 20, 2025

Patients With Obesity More Likely to Be Diagnosed With Earlier-Stage Melanoma

Individuals with obesity and serious comorbidities significantly more likely to have earlier T-stage at diagnosis

By Dermsquared Editorial Team | | August 20, 2025

Lebrikizumab Efficacious, Safe for Patients With Skin of Color, Eczema

64.4 percent of patients with postinflammatory hyperpigmented lesions at baseline experienced reduced hyperpigmentation at week 24

By Elana Gotkine (HealthDay News) | | August 20, 2025

Public Believes Dermatologic Side Effects From Cancer Treatment Are Common

Findings seen among both those previously treated for cancer and cancer-naive people

By Lori Solomon (HealthDay News) | | August 20, 2025

Firefighters Face Elevated Mortality Rates for Skin and Kidney Cancer

Suggestive increases for prostate and colorectal cancer mortality observed with more years as a firefighter

By Dermsquared Editorial Team | | August 11, 2025

Researchers Identify Risk Thresholds Using 40-GEP to Manage Decisions for cSCC

40-gene expression profiling can inform adjuvant radiation therapy and surveillance imaging decision-making

By Elana Gotkine (HealthDay News) | | August 11, 2025

Interclass Biologic Switching Effective for Patients With Psoriasis

Highest risk for infection associated with switching from anti-TNF-α to anti-IL-23p19, anti-IL-17A, anti-IL-12/23p40

By Elana Gotkine (HealthDay News) | | August 11, 2025

LAUNCH ALERT: FDA Approves Anzupgo (Delgocitinib) Cream for Moderate-to-Severe Chronic Hand Eczema in Adults

The topical pan-JAK inhibitor is the first FDA-approved therapy specifically indicated for chronic hand eczema

By Dermsquared Editorial Team | | August 06, 2025

40-Gene Expression Profile Predicts Local Recurrence in High-Risk cSCC

Three-year local recurrence-free survival, metastasis-free survival higher for class 1 versus class 2A or 2B patients

By Dermsquared Editorial Team | | August 04, 2025

Risk for New-Onset Depression, Anxiety Elevated for Patients With Hidradenitis Suppurativa

No consistent differences seen across severity levels using treatment and HS-related surgical procedures as markers of severity

By Dermsquared Editorial Team | | August 04, 2025

FDA Approves First Cream for Treating Chronic Hand Eczema

Key Takeaways

  • The U.S. Food and Drug Administration has given its nod to a new treatment for chronic hand eczema
  • Anzupgo is now the...
By Denise Mann (HealthDay News) | | August 04, 2025

Alopecia Areata Associated With Severe Psychosocial Impact

High levels of anxiety, depression, stigma, and impaired QoL reported by many patients; all linked to perceptions of illness

By Elana Gotkine (HealthDay News) | | August 04, 2025

24 of 1200

Headline from the Week of February 09 - 15, 2026

Second Annual National Cancer Database Report Presented for 2022

By Elana Gotkine (HealthDay News) | | February 11, 2026

Presurgical Pembrolizumab Beneficial for Desmoplastic Melanoma

By Elana Gotkine (HealthDay News) | | February 11, 2026